Skip to Content

M LN4 (Lamivudine 100 mg)

Pill with imprint M LN4 is Peach, Capsule-shape and has been identified as Lamivudine 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LN4

Lamivudine 100 mg M LN4
Lamivudine 100 mg M LN4
Lamivudine 100 mg M LN4

Lamivudine

Imprint
M LN4
Strength
100 mg
Color
Peach
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5168

Get help with Imprint Code FAQs.

Related Images for "M LN4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.